✦ LIBER ✦

Cost-effectiveness evaluation of fixed-dose combination of angiotensin-II receptor blockers with and without hydrochlorothiazide

✍ Scribed by Daniel E Hilleman; Richard L Wurdeman; Thomas L Lenz

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Maximising antihypertensive effects of a

✍ J. M. Flack 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 203 KB

Results of Increasing Doses of Hydrochlo

✍ Steen Neldam; Colin Edwards 📂 Article 📅 2008 🏛 Le Jacq Communications, Inc. 🌐 English ⚖ 927 KB

Efficacy and safety of combination thera

✍ R. Fuenfstueck; R. -D. Hempel; A. Ansari; G. Weidinger; S. Klebs 📂 Article 📅 2005 🏛 Springer Healthcare Communications 🌐 English ⚖ 412 KB

Rationale for triple fixed-dose combinat

✍ Volpe, Massimo; Tocci, 📂 Article 📅 2012 🏛 Dove Press Ltd. 🌐 English ⚖ 346 KB

PCV59 PERSISTENCE AND COMPLIANCE IN HYPE

✍ A. Sandberg; K. Kostev; B. Ehlken; B. Holz; A. Oberdiek 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 56 KB

Effects of the Angiotensin II Receptor B

✍ William B. White; Henry A. Punzi; Debra Murwin; Stephen E. Koval; Giora Davidai; 📂 Article 📅 2006 🏛 Le Jacq Communications, Inc. 🌐 English ⚖ 257 KB